Anant Vatsayan

Anant Vatsayan

Pediatrics
111 Michigan Avenue Northwest, Childrens National Telemedicine
Washington, DC 20010

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications

High Predicted Thiotepa Exposure is Associated with Increased Risk of Thrombotic Microangiopathy and Non-Relapse Mortality in Pediatric Patients Undergoing Alpha-Beta T-Cell Depleted Haploidentical Transplantation.

High Predicted Thiotepa Exposure is Associated with Increased Risk of Thrombotic Microangiopathy and Non-Relapse Mortality in Pediatric Patients Undergoing Alpha-Beta T-Cell Depleted Haploidentical Transplantation.

Journal: Transplantation and cellular therapy
Published: June 09, 2026

Early Acute Leukemia Relapse After CD19-Directed CAR-T With Lineage Switch From B to T-ALL in a Pediatric Patient.

Early Acute Leukemia Relapse After CD19-Directed CAR-T With Lineage Switch From B to T-ALL in a Pediatric Patient.

Journal: Pediatric blood & cancer
Published: May 22, 2026

HLH-like syndromes associate with increased risk of death and CD19-negative relapse post-CAR T in pediatric B-ALL.

HLH-like syndromes associate with increased risk of death and CD19-negative relapse post-CAR T in pediatric B-ALL.

Journal: Blood advances
Published: March 24, 2026

Endothelial activation and stress index score as a predictor of transplant-associated thrombotic microangiopathy in patients with sickle cell disease.

Endothelial activation and stress index score as a predictor of transplant-associated thrombotic microangiopathy in patients with sickle cell disease.

Journal: British journal of haematology
Published: November 21, 2025

Erratum to 'Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome'[Transplant Cell Ther. 2023 Jul;29(7):438.e1-438.e16. Epub 2023 Mar 9].

Erratum to 'Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome'[Transplant Cell Ther. 2023 Jul;29(7):438.e1-438.e16. Epub 2023 Mar 9].

Journal: Transplantation and cellular therapy
Published: October 09, 2025

Characterization and prediction of prolonged severe neutropenia in pediatric patients receiving tisagenlecleucel.

Characterization and prediction of prolonged severe neutropenia in pediatric patients receiving tisagenlecleucel.

Journal: Blood advances
Published: April 14, 2025

PTCy unchained in matched siblings: the D is silent in GVHD.

PTCy unchained in matched siblings: the D is silent in GVHD.

Journal: Blood advances
Published: February 11, 2025

Harnessing virus-specific T cells: expanding therapeutic strategies across diverse populations.

Harnessing virus-specific T cells: expanding therapeutic strategies across diverse populations.

Journal: Blood advances
Published: November 27, 2024

Pediatric Myelodysplastic Syndrome: Updated Classifications and Current Diagnosis and Treatment Challenges.

Pediatric Myelodysplastic Syndrome: Updated Classifications and Current Diagnosis and Treatment Challenges.

Journal: Archives of pathology & laboratory medicine
Published: September 11, 2024

Project EVOLVE: an international analysis of postimmunotherapy lineage switch, an emergent form of relapse in leukemia.

Project EVOLVE: an international analysis of postimmunotherapy lineage switch, an emergent form of relapse in leukemia.

Journal: Blood
Published: September 09, 2024

Philadelphia chromosome-like B-acute lymphoblastic leukemia and disseminated juvenile xanthogranulomatosis with shared KRAS mutation.

Philadelphia chromosome-like B-acute lymphoblastic leukemia and disseminated juvenile xanthogranulomatosis with shared KRAS mutation.

Journal: Pediatric blood & cancer
Published: February 21, 2024

Real-world use of tisagenlecleucel in children and young adults with relapsed or refractory B-cell lymphomas.

Real-world use of tisagenlecleucel in children and young adults with relapsed or refractory B-cell lymphomas.

Journal: Blood advances
Published: February 16, 2024
Showing 1-12 of 32

Last Updated: 09/26/2026